Cancer expert doubts claims about prostate cancer trial.
Cole
Andrew
A
D000736:Androstenes; D000737:Androstenols / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000736:Androstenes; D000737:Androstenols; D000970:Antineoplastic Agents; C089740:abiraterone